Videos
OnabotulinumtoxinA for Preventative Migraine Treatment
Stephanie J. Nahas, MD, MSEd, FAHS, FAAN, provides an overview of the use of onabotulinumtoxinA as a preventive migraine treatment.
Discussing Novel Agents for Preventative Migraine Therapy with Patients
A thought leader explains how she involves the patient when selecting novel agents to add to a preventive migraine treatment plan.
Clinical, Radiological Features of NMOSD and MOGAD: Amy Kunchok, MD
December 16th 2021The staff neurologist at the Cleveland Clinic Mellen Center for Multiple Sclerosis outlined key findings from her talk at a recent Institutional Perspectives in Neurology: Multiple Sclerosis event. [WATCH TIME: 3 minutes]
Maintaining a High Level of Migraine Care in the ED Setting: Anne-Maree Kelly, MD
December 16th 2021The director of the Joseph Epstein Center for Emergency Medicine Research discussed the complexities of diagnosing migraine in the emergency department and whether institutions should reevaluate their internal processes to do so. [WATCH TIME: 3 minutes]
Understanding the Care for Headache in Emergency Departments: Anne-Maree Kelly, MD
December 14th 2021The director of the Joseph Epstein Center for Emergency Medicine Research discussed the origin behind her multinational study evaluating the outcome of headache in emergency departments. [WATCH TIME: 3 minutes]
Ganaxolone’s Potential in TSC, Need for More Drug Development: Darcy Krueger, MD, PhD
December 12th 2021The director of the Tuberous Sclerosis Clinic at Cincinnati Children’s discussed the phase 2 open-label study of ganaxolone in TSC and whether drug development remains the top priority for these patients. [WATCH TIME: 3 minutes]
Recent Advances, Future Developments in Epilepsy Surgery: Imad Najm, MD
December 10th 2021The director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute spoke on the latest advances with epilepsy surgery, as well as what still needs to be learned. [WATCH TIME: 5 minutes]
Behavioral Treatment Strategies for Migraine Management
An expert panel discusses migraine prevention with the use of behavioral therapies such as cognitive behavioral therapy and stress management.
Cenobamate’s Efficacy Profile in Treating Seizures: William Rosenfeld, MD
December 9th 2021The neurologist from the Comprehensive Epilepsy Care Center for Children and Adults, in St. Louis, Missouri, discussed numerous presentations from AES 2021 that bolstered cenobamate’s known efficacy and safety profile. [WATCH TIME: 7 minutes]
Vaccination and Seizure Risk in Dravet Syndrome: Veronica Hood, PhD, MS
December 8th 2021The scientific director at the Dravet Syndrome Foundation commented on the concern associated with vaccination in this patient population, noting that investigators have not observed an exacerbated risk profile with the COVID-19 vaccines. [WATCH TIME: 2 minutes]
Exploring the Benefits of CBT for Psychogenic Non-Epileptic Seizures: Becky Tilahun, PhD
December 5th 2021The clinical psychologist at Cleveland Clinic discussed the potential of using cognitive behavioral therapy for treatment of psychogenic non-epileptic seizures on cognitive behavioral therapy. [WATCH TIME: 3 minutes]
